Your browser doesn't support javascript.
loading
Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society.
Nakai, Michikazu; Iwanaga, Yoshitaka; Kanaoka, Koshiro; Sumita, Yoko; Nishioka, Yuichi; Myojin, Tomoya; Kubo, Shinichiro; Okada, Katsuki; Soeda, Tsunenari; Noda, Tatsuya; Sakata, Yasushi; Imamura, Tomoaki; Saito, Yoshihiko; Yasuda, Satoshi; Miyamoto, Yoshihiro.
Afiliação
  • Nakai M; Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Japan.
  • Iwanaga Y; Department of Biostatistics, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Kanaoka K; Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Japan. yiwanaga@ncvc.go.jp.
  • Sumita Y; Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Japan.
  • Nishioka Y; Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, 6-1 Kishibeshimmachi, Suita, Japan.
  • Myojin T; Department of Public Health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
  • Kubo S; Department of Public Health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
  • Okada K; Department of Public Health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
  • Soeda T; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
  • Noda T; Department of Transformative System for Medical Information, Osaka University Graduate School of Medicine, Suita, Japan.
  • Sakata Y; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.
  • Imamura T; Department of Public Health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
  • Saito Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
  • Yasuda S; Department of Public Health, Health Management and Policy, Nara Medical University, Kashihara, Japan.
  • Miyamoto Y; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.
Cardiovasc Diabetol ; 21(1): 157, 2022 08 13.
Article em En | MEDLINE | ID: mdl-35964039

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article